About Kritika Sarmah
Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist.
She earned her bachelor's degree in commerce and is currently pursuing the CFA program.
With her fundamental approach, she aims to help investors identify untapped investment opportunities.
Recent Articles By Kritika Sarmah
1 Tech Stock with a Promising Future to Buy Now
Leading tech company IBM had a solid 2022 despite high inflation and reported its highest annual revenue growth in more than a decade. Moreover, with AI investing gaining popularity, the stock looks well-positioned to soar. Read more...
1 No-Brainer Momentum Stock to Buy This Week
Prominent energy stock Marathon Petroleum (MPC) is currently trading above its 50-day and 200-day moving averages. Moreover, given the analysts’ bullish sentiments about the stock, it could be a solid pick this week. Keep reading...
3 Other Chip Stocks to Check out in Addition to TSM
The chips industry’s long-term prospects look promising due to the exponential rise in demand. While Taiwan Semiconductor (TSM) has gained significant popularity among investors, United Microelectronic (UMC), MasxLinear (MXL), and CEVA (CEVA) could be worth checking out. Keep reading...
4 Stocks You’ll Be Glad You Bought in 2023
While inflation showed signs of slowing, it is still far from the Fed’s target. Moreover, a tight labor market strengthens the case for higher rate hikes. Hence, fundamentally strong stocks Stellantis (STLA), General Motors (GM), Textron (TXT), and Modine (MOD), which look well-positioned to whether a market downturn, might be solid buys now. Keep reading...
2 Best Gambling Stocks to Buy in 2023 and 1 to Avoid
While digital innovations continue to boost the gambling industry, strict regulations might hamper the industry’s prospects. We think fundamentally strong gambling stocks Boyd Gaming (BYD) and Accel Entertainment (ACEL) are poised to deliver steady returns and might be solid buys this year. However, fundamentally weak DraftKings (DKNG) might be best avoided. Continue reading...
2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling
The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, with a recession lurking, fundamentally strong pharma stocks AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) might be ideal buys. However, SNDL (SNDL) might be best avoided. Keep reading to know why...
Vishay Intertechnology Stock: Buy, Sell or Hold in March?
Rising interest rates and recession fears have been weighing on the stock market. Semiconductor stock Vishay Intertechnology (VSH) has declined in price over the past month. And considering the macro uncertainties, should you buy, sell or hold VSH in March 2023? Continue reading to find out...
1 Software Stock You Can Confidently Buy Now and Hold Forever
Software giant Oracle (ORCL) is well-positioned to drive profitability from the current craze of AI. Moreover, the company’s collaborations with top industry peers and new launches should drive growth. The stock look poised to deliver steady returns and might be an ideal buy now. Read on...
5 Best Stocks Long-Term Investors Can Buy Right Now
Amid concerns that sticky inflation might lead to more rate hikes, the stock market is expected to remain volatile in the near term. So, investors should focus on their long-term strategy and scoop up quality stocks McDonald's (MCD), Verizon (VZ), Salesforce (CRM), Humana (HUM), and STMicroelectronics (STM), which look poised for long-term growth. Keep reading...